Società Alexion Pharmaceuticals, Inc.
Azioni
ALXN
US0153511094
Prodotti farmaceutici
Attività
Le vendite nette sono distribuite geograficamente come segue: Stati Uniti (59,4%), Europa (21,9%), Asia/Pacifico (10,9%) e altro (7,8%).
Numero di dipendenti: 3 837
Vendite per attività
USD in Milioni | 2019 | Peso | 2020 | Peso | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100,0
%
| 4 990 | 100,0 % | 6 069 | 100,0 % | +21,63% |
Vendite per regione
USD in Milioni | 2019 | Peso | 2020 | Peso | Delta |
---|---|---|---|---|---|
United States
59,4
%
| 2 763 | 55,4 % | 3 604 | 59,4 % | +30,46% |
Europe
21,9
%
| 1 206 | 24,2 % | 1 327 | 21,9 % | +10,02% |
Asia Pacific
10,9
%
| 528 | 10,6 % | 664 | 10,9 % | +25,59% |
Rest of the World
7,8
%
| 493 | 9,9 % | 475 | 7,8 % | -3,73% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Marc Dunoyer
CEO | Chief Executive Officer | 71 | - |
Sean Christie
DFI | Director of Finance/CFO | - | 01/08/21 |
Chief Tech/Sci/R&D Officer | - | 01/12/20 | |
Ruth Diazaraque
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/23 |
Seng Cheng
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/23 |
Piyush Sharma
CMP | Compliance Officer | - | 01/08/17 |
Patryk Mikucki
CTO | Chief Tech/Sci/R&D Officer | 49 | - |
Todd Spalding
LAW | General Counsel | - | - |
Sarah Marshall
HRO | Human Resources Officer | - | 01/01/14 |
Glen Frick
PRN | Corporate Officer/Principal | 57 | - |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 243 075 313 | 221 078 742 ( 90,95 %) | 21 400 000 ( 8,804 %) | 90,95 % |
Coordinate società
Alexion Pharmaceuticals, Inc.
121 Seaport Boulevard
02210, Boston
+(475) 230 2596
http://www.alexion.comSocietà del gruppo
Nome | Categoria e settore |
---|---|
Alexion Pharma GmbH
| |
Alexion Pharma International Operations Ltd.
Alexion Pharma International Operations Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Alexion Pharma International Operations Ltd. wholesales drugs, proprietaries and sundries. The private company is based in Dublin, Ireland. |
Pharmaceuticals: Major
|
Alexion Pharma Holding Unlimited Co.
Alexion Pharma Holding Unlimited Co. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Alexion Pharma Holding Unlimited Co. is an Irish company that develops biologic therapeutic products. The private company is located in Ireland. |
Pharmaceuticals: Major
|
Alexion Business Services Pvt Ltd.
|
Settore
Vendite per regione
Variaz. 1 gen. | Capi. | |
---|---|---|
+25,83% | 661 Mrd | |
+27,00% | 566 Mrd | |
-6,76% | 352 Mrd | |
+20,34% | 332 Mrd | |
+3,00% | 283 Mrd | |
+13,09% | 231 Mrd | |
+5,46% | 200 Mrd | |
-9,61% | 195 Mrd | |
-6,26% | 145 Mrd |